506 The tumor immune microenvironment of metastatic osteosarcoma is marked by lymphocyte exclusion and impacts patient progression-free survival

• Wei Fu,
• Gady Cojocaru,
• Teniola Oke,
• Robert Anders,
• John Ligon,
• Woonyoung Choi,
• Carol Morris,
• Adam Levin,
• Daniel Rhee,
• David McConkey,
• Nicolas Llosa

Affiliations

Wei Fu

4JHU, Baltimore, MD, USA

Gady Cojocaru

Aff1 grid.418916.30000 0004 0506 4804Compugen Ltd. Israel

Teniola Oke

Aff1 0000 0001 2171 9311grid.21107.35Bloomberg-Kimmel Institute for Cancer ImmunotherapyJohns Hopkins University Baltimore MD USA

Robert Anders

Aff1 0000 0001 2171 9311grid.21107.35Johns Hopkins University School of Medicine Baltimore MD USA

John Ligon

1National Cancer Institute Pediatric Oncology Branch, and Johns Hopkins University School of Medicine, Bethesda, MD, USA

Woonyoung Choi

2Greenberg Bladder Cancer Institute (JHU), Baltimore, MD, USA

Carol Morris

4JHU, Baltimore, MD, USA

Adam Levin

4JHU, Baltimore, MD, USA

Daniel Rhee

4JHU, Baltimore, MD, USA

David McConkey

4JHU, Baltimore, MD, USA

Nicolas Llosa

4JHU, Baltimore, MD, USA